C-Reactive Protein for Predicting Prognosis and Its Gender-Specific Associations with Diabetes Mellitus and Hypertension in the Development of Coronary Artery Spasm

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Hung, Ming Jui ^a   Hsu, Kuang Hung ^b   Hu, Wei Syun ^c   Chang, Nen Chung ^d   Hung, Ming Yow ^a,c,e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY SPASM; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; SPASM; YOUNG ADULT;

EID: 84886610101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077655     Document Type: Article

References (42)

1. Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, et al. (2013) Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease. PLoS One 8: e60163.
2. Hung MY, Hsu KH, Hung MJ, Cheng CW, Cherng WJ, (2010) Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm. Eur J Clin Invest 40: 1094-1103.
3. Dumont T, Rughani A, Silver J, Tranmer BI, (2009) Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care 11: 183-189.
4. Nugent AG, McGurk C, Hayes JR, Johnston GD, (1996) Impaired vasoconstriction to endothelin 1 in patients with NIDDM. Diabetes 45: 105-107.
5. Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, et al. (2004) Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 125: 823-830.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
7. Sugiishi M, Takatsu F, (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87: 76-79.
8. Sato I, Tomita M, Ohe T, Haze K, Shimomura K, (1986) Age-related changes of clinical features and prevalences of coronary risk factors in Japanese patients with vasospastic angina. Chest 89: 12-19.
9. Kozàkovà M, Galetta F, Gregorini L, Bigalli G, Franzoni F, et al. (2000) Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension 36: 343-349.
10. Crabos M, Coste P, Paccalin M, Tariosse L, Daret D, et al. (1997) Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 29: 55-65.
11. Fernández N, Angeles Martínez M, García-Villalón AL, Monge L, Diéguez G (2002) Coronary effects of endothelin-1 during acute hypertension in anaesthetized goats. Clin Sci (Lond) (Suppl 48): 376S-379S.
12. Kauser K, Rubanyi GM, (1995) Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25: 517-523.
13. Hung MY, Hsu KH, Hu WS, Chang NC, Huang CY, et al. (2013) Gender-Specific Prognosis and Risk Impact of C-Reactive Protein, Hemoglobin and Platelet in the Development of Coronary Spasm. Int J Med Sci 10: 255-264.
14. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, et al. (1996) Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 17: 1015-1021.
15. Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S, (2012) Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care 35: 396-403.
16. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al. (2003) Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
17. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR, (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565.
18. Oltman CL, Gutterman DD, Scott EC, Bocker JM, Dellsperger KC, (1997) Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res 34: 179-184.
19. Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, et al. (2010) Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test. J Hum Hypertens 24: 77-85.
20. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, et al. (1999) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 99: 2829-2848.
21. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J 74: 1745-1762.
22. Sharaf BL, Williams DO, Miele NJ, McMahon RP, Stone PH, et al. (1997) A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory. J Am Coll Cardiol 29: 78-84.
23. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, et al. (2000) Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 36: 432-437.
24. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, et al. (2007) Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 28: 806-813.
25. Karanian JW, Ramwell PW, (1996) Effect of gender and sex steroids on the contractile response of canine coronary and renal blood vessels. J Cardiovasc Pharmacol 27: 312-319.
26. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R, (1997) Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 100: 678-684.
27. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, et al. (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation 112: 1289-1295.
28. Tschudi MR, Luscher TF, (1995) Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. Circulation 91: 2415-2422.
29. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, et al. (1999) Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 17: 1099-1107.
30. Sanz E, Fernández N, Monge L, Martínez MA, Climent B, et al. (2003) Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: gender and regional differences. Life Sci 72: 1537-1547.
31. Grunwald JE, Riva CE, Martin DB, Quint AR, Epstein PA, (1987) Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology 94: 1614-1620.
32. Pieper GM, (1999) Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42: 204-213.
33. Lynch FM, Izzard AS, Austin C, Prendergast B, Keenan D, et al. (2012) Heagerty AM. Effects of diabetes and hypertension on structure and distensibilty of human small coronary arteries. J Hypertens 30: 384-389.
34. Schofield I, Malik R, Izzard A, Austin C, Heagerty A, (2002) Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106: 3037-3043.
35. Liu L, Fan QI, El-Zaru MR, Vanderpool K, Hines RN, et al. (2000) Regulation of DHP receptor expression by elements in the 5′-flanking sequence. Am J Physiol Heart Circ Physiol 278: H1153-H1162.
36. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, et al. (1995) 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 294: 625-635.
37. Ajayi AA, Hercule H, Cory J, Hayes BE, Oyekan AO, (2003) Gender difference in vascular and platelet reactivity to thromboxane A(2)-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats. Diabetes Res Clin Pract 59: 11-24.
38. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE, (2002) Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 53: 538-549.
39. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
40. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397.
41. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, et al. (1997) Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17: 1121-1127.
42. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U, (2011) 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol 57: 147-152.